Michael J Roberts
CIK 1481629 · President and CEO · last filed 2025-09-10
Michael J Roberts is a President and CEO who has filed 9 SEC Form 4 insider transactions across 1 company since 2010. Across all open-market trades the lifetime net is +$6.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$6.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Chelsea Therapeutics International, Ltd. (CHTP) Delisted | VP, Business Development | 22,000 | — | — | $6.2K | 8 | 2014-01-24 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-10 | — | Grant (A) | — | $0 | |
| 2014-01-24 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-09 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-07-19 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-07-11 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-27 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-13 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-08-12 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Buy (P) | +2,000 | $6.2K | EDGAR |
| 2010-01-21 | Chelsea Therapeutics International, Ltd. (CHTP) Delisted | Grant (A) | — | $0 | EDGAR |